SWOT Analysis:
Strength: Ticagrelor has strong efficacy and safety profile for treatment of acute coronary syndrome. It has demonstrated significant reduction in risk of myocardial infarction, stroke or cardiovascular death.Weakness: Being a relatively new drug, its long term safety is not well established yet. It also has some side effects like bleeding risk which limits its usage.Opportunity:...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian